https://www.selleckchem.com/pr....oducts/acetohydroxam
35), male **** (HR, 1.75), lower baseline LVEF (HR, 1.02), worse LV-GLS (HR, 1.04), neurologic trigger (HR, 2.66), and physical trigger (HR, 2.64) were associated with mortality, whereas aspirin (HR, 0.7 and β-blockers (HR, 0.73) improved survival (all P less then 0.049). The addition of LVEF and LV-GLS to clinical markers (age, ****, cardiogenic shock at presentation, and peak troponin I) significantly increased log-likelihood ratios clinical (-521.48), clinical plus LVEF (-511.32, P less then 0.001), and clinical plus LVE
Kao
Komentar
Udio
